These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14743047)

  • 1. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
    Lee KY; Han JW; Lee HS; Hong JH; Hahn SH; Lee JS; Whang KT
    Pediatr Infect Dis J; 2004 Jan; 23(1):52-5. PubMed ID: 14743047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A; Prachuabmoh C; Kangkagate C
    Pediatr Cardiol; 2003; 24(2):145-8. PubMed ID: 12457253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002.
    Saffar MJ; Reshidighader F
    East Mediterr Health J; 2005; 11(1-2):28-35. PubMed ID: 16532668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological survey of Kawasaki disease in Sichuan province of China.
    Li XH; Li XJ; Li H; Xu M; Zhou M
    J Trop Pediatr; 2008 Apr; 54(2):133-6. PubMed ID: 17965438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C; Kirawitaya T; Layangkool T; Nawasiri W; Vimolsarawong N
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M; Chaikitpinyo A; Durongpisitkul K; Somchit S; Petcharatana S; Wongswadiwat Y; Kosalaraksa P; Lumbiganon P
    J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
    Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U
    J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological investigation of Kawasaki disease in Jilin province of China from 2000 to 2008.
    Piao JH; Jin LH; Lv J; Zhou Y; Jin CJ; Jin ZY
    Cardiol Young; 2010 Aug; 20(4):426-32. PubMed ID: 20420740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002.
    Chang LY; Chang IS; Lu CY; Chiang BL; Lee CY; Chen PJ; Wang JT; Ho HN; Chen DS; Huang LM;
    Pediatrics; 2004 Dec; 114(6):e678-82. PubMed ID: 15574600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP; Yan WL; Huang M; Huang MR; Chen S; Huang GY; Liu F
    J Epidemiol; 2020 Oct; 30(10):429-435. PubMed ID: 31548437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiologic study of admitted children with Kawasaki disease in Beijing from 1995 to 1999].
    Du ZD; Liang L; Meng XP; Li T; Zhang TH; Kawasaki T; Yanagawa H;
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1874-8. PubMed ID: 14642070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.